Mouse Glucose-dependent insulin-releasing polypeptide,GIP ELISA Kit

Code CSB-E08486m
Size 96T,5×96T,10×96T
Price Request a Quote or Start an on-line Chat
Trial Size 24T ELISA Kit Trial Size (Only USD$150/ kit)
* The sample kit cost can be deducted from your subsequent orders of 96T full size kits of the same analyte at 1/5 per kit, until depleted in 6 months. Apply now

Product Details

Target Name
gastric inhibitory polypeptide
Alternative Names
GipGastric inhibitory polypeptide ELISA Kit; GIP ELISA Kit; Glucose-dependent insulinotropic polypeptide ELISA Kit
Abbreviation
GIP
Uniprot No.
Species
Mus musculus (Mouse)
Sample Types
serum, plasma, tissue homogenates
Detection Range
0.156 ng/mL-10 ng/mL
Sensitivity
0.039 ng/mL
Assay Time
1-5h
Sample Volume
50-100ul
Detection Wavelength
450 nm
Research Area
Signal Transduction
Assay Principle
quantitative
Measurement
Sandwich
Precision
Intra-assay Precision (Precision within an assay): CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess.
Inter-assay Precision (Precision between assays): CV%<10%
Three samples of known concentration were tested in twenty assays to assess.
Linearity
To assess the linearity of the assay, samples were spiked with high concentrations of mouse GIP in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
  Sample Serum(n=4)
1:1 Average % 88
Range % 84-92
1:2 Average % 97
Range % 94-101
1:4 Average % 102
Range % 97-108
1:8 Average % 94
Range % 89-98
Recovery
The recovery of mouse GIP spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample Type Average % Recovery Range
Serum (n=5) 102 98-107
EDTA plasma (n=4) 93 82-97
Typical Data
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
ng/ml OD1 OD2 Average Corrected
10 2.134 2.257 2.196 2.080
5 1.675 1.739 1.707 1.591
2.5 1.144 1.185 1.165 1.049
1.25 0.672 0.696 0.684 0.568
0.625 0.404 0.423 0.414 0.298
0.312 0.288 0.293 0.291 0.175
0.156 0.202 0.209 0.206 0.090
0 0.115 0.117 0.116  
Troubleshooting
and FAQs
Storage
Store at 2-8°C. Please refer to protocol.
Lead Time
3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx
Description

This Mouse GIP ELISA Kit was designed for the quantitative measurement of Mouse GIP protein in serum, plasma, tissue homogenates. It is a Sandwich ELISA kit, its detection range is 0.156 ng/mL-10 ng/mL and the sensitivity is 0.039 ng/mL.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
(From Uniprot)
Potent stimulator of insulin secretion and relatively poor inhibitor of gastric acid secretion.
Gene References into Functions
  1. GIP stimulation induces a switch in GIPR recycling from a rapid endosomal to a slow trans-Golgi network (TGN) pathway. GPCR kinases and b-arrestin2 are required for this switch in recycling. PMID: 27974210
  2. GIP provides a novel link between the immune system and the gut, with proinflammatory-immune modulatory function but minor glucose regulatory relevance in the context of acute endotoxemia. PMID: 27350651
  3. our data suggest that the metabolic hormone GIP plays an important role in bone marrow hematopoiesis PMID: 28250160
  4. It was demonstrated that cardiomyocytes represent a direct target of GIP action in vitro, and that GIP ameliorated AngII-induced cardiac hypertrophy via suppression of cardiomyocyte enlargement, apoptosis, and fibrosis in vivo. PMID: 27375170
  5. The loss of food-induced GIP response in Roux-limb of intestine likely contributes to the attenuated serum GIP response to feeding. PMID: 26266950
  6. GIP induces the expression of the proatherogenic cytokine osteopontin (OPN) in mouse arteries via local release of endothelin-1 and activation of CREB. GIPR mRNA is higher in symptomatic carotid endarterectomy patients. PMID: 26395740
  7. These studies support the hypothesis that a reduction in GIP signaling using a GIP-neutralizing mAb might provide a useful method for the treatment and prevention of obesity and related disorders. PMID: 26487006
  8. This study provides evidences that GIP acts directly on osteoblasts and is capable of improving collagen maturity and fibril diameter. PMID: 25582623
  9. There was decrease in GIP gene transcripts and protein in the gut of HNF1a-null mice. PMID: 25979074
  10. Circulating levels of GIP were significantly decreased in FABP5-deficient mice. PMID: 25268051
  11. phosphatidylinositol 3-kinase gamma has a role in insulin secretion induced by glucose-dependent insulinotropic polypeptide PMID: 25288806
  12. The results describe key beneficial immunoregulatory properties for glucose-dependent insulinotropic polypeptide in diet-induced obesity and reveal that its augmentation ameliorates adipose tissue inflammation and improves insulin resistance. PMID: 25217161
  13. GIP-reduced mice demonstrate that partial reduction of GIP does not extensively alter glucose tolerance, but it alleviates obesity and lessens the degree of insulin resistance under high-fat diet conditions, suggesting a potential therapeutic value. PMID: 24584548
  14. It was concluded from these observations that GIP, but not glucagon-like peptide-1, directly activates PepT1 activity by a cAMP-dependent signaling pathway in jejunum. PMID: 24072682
  15. A novel acylated form of (d-Ala(2))GIP with improved antidiabetic potential, lacking effect on body fat stores. PMID: 23518200
  16. The results indicated that ectopic glucose-dependent insulinotropic polypeptide expression in pancreatic beta cells maintains insulin secretion in the absence of proglucagon-derived peptides, revealing a novel mechanism for sustaining incretin action. PMID: 23099862
  17. Rfx6 increases GIP expression and content in enteroendocrine K-cells and is involved in GIP hypersecretion in high fat diet-induced obesity. PMID: 23192339
  18. GIP signaling may play a role in early embryonic pancreas differentiation to form insulin-positive cells or beta-cells. PMID: 21270265
  19. truncated forms of GIP exhibit potent anti-diabetic actions, without pro-obesity effects, and that the C-terminus contributes to the lipogenic actions of GIP PMID: 20231880
  20. GIP is expressed in and secreted from pancreatic islets and promotes islet glucose competence and also could support islet development and/or survival. PMID: 20138041
  21. substantial quantities of glycated GIP exist within the intestines of diabetic ob/ob mice, suggesting that this may be a contributing factor to the physiological disarray of this syndrome PMID: 11954659
  22. a novel pathway of obesity promotion via GIP; GIP directly links overnutrition to obesity PMID: 12068290
  23. Novel insulin/GIP co-producing cell lines provide unexpected insights into Gut K-cell function in vivo. PMID: 12124779
  24. Calcium mobilization from intracellular and extracellular sources, independent from K(ATP) channels, regulates secretion from some, but not all, subpopulations of enteroendocrine cells. PMID: 12676650
  25. GIP is the major insulinotropic factor in the secretion of insulin in response to glucose load in K(ATP) channel-deficient mice. PMID: 15362972
  26. Transcription factor PDX-1 plays a critical role in the cell-specific expression of the GIP gene. PMID: 15486225
  27. The physiological importance of glucose-dependent insulinotropic polypeptide has been investigated in single and double incretin receptor knockout mice. PMID: 15780432
  28. PI3K/PKB/Foxo1 signaling mediates GIP suppression of bax gene expression, which is a key pathway by which GIP regulates beta-cell apoptosis in vivo PMID: 15817464
  29. GIP plays a crucial role in switching from fat oxidation to fat accumulation under the diminished insulin action as a potential target for secondary prevention of insulin resistance PMID: 16105663
  30. Because GIPR(-/-) mice exhibited an increased plasma calcium concentration after meal ingestion, GIP directly links calcium contained in meal to calcium deposition on bone. PMID: 16469773
  31. Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor PMID: 16476726
  32. protein kinase B, LKB1, and AMP-activated protein kinase have roles in activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes PMID: 17244606
  33. Glucose-dependent insulinotropic peptide inhibits bone resorption and stimulates bone formation PMID: 17321229
  34. First characterization of the anatomical distribution of GIP-immunoreactive cells in the rat brain providing an anatomical framework for future investigations regarding the functions of GIP in the central nervous system. PMID: 17510976
  35. Administration of resistin to adipocytes mimicked the effects of GIP on the PKB/LKB1/AMPK/LPL pathway: increasing phosphorylation of PKB, reducing levels of phosphorylated LKB1 and AMPK, and increasing LPL activity. PMID: 17890220
  36. genetic inactivation of GIP signaling can prevent the development of aging-associated insulin resistance through body composition changes PMID: 17937928
  37. GATA-4 may function to augment or enhance GIP expression rather than act as an initiator of GIP transcription. PMID: 18343025
  38. Gpr40 modulates FFA-stimulated insulin secretion from beta-cells not only directly but also indirectly via regulation of incretin(GIP and GLP-1) secretion PMID: 18519800
  39. The GIP-induced increase in glucose transport appears to be mediated, at least in part, by SGLT-1. PMID: 18719661
  40. These results indicate that inhibition of GIP signaling increases adiponectin levels, resulting in increased fat oxidation in peripheral tissues under high-fat diet. PMID: 18723001

Show More

Hide All

Subcellular Location
Secreted.
Protein Families
Glucagon family
Database Links
icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalization X